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The ongoing COVID-19 pandemic highlighted a significant interplay between cardiovascular 
disease (CVD), COVID-19 related inflammatory status, and depression. Cardiovascular (CV) injury 
is responsible for a substantial percentage of COVID-19 deaths while COVID-19 social restrictions 
emerged as a non-negligible risk factor for CVD as well as a variety of mental health issues, and in 
particular, depression. Inflammation seems to be a shared condition between these two disorders.  
Gender represents a potential modifying factor both in CVD and depression, as well as in COVID-
19 short- and long-term outcomes, particularly in cases involving long-term COVID complications.  
Results from emerging studies indicate that COVID-19 pandemic affected male and female 
populations in different ways. Women seem to experience less severe short-term complications but 
suffer worse long-term COVID complications, including depression, reduced physical activity, and 
deteriorating lifestyle habits, all of which may impact CV risk. Here, we summarize the current 
state of knowledge about the interplay between COVID-19, depression, and CV risk in women.  
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Introduction  
Cardiovascular (CV) injury is associated with a significant proportion of COVID-19 deaths and a 
preexisting cardiovascular disease (CVD) is one of the most common risk factors for hospitalization 
and death in COVID-19 patients. (1) On the other hand, the health policy reactions to the COVID-
19 pandemic, with lockdown and significant movement restriction, have already been proven to 
determine widespread effects on CV risk, affecting both the general population and the survivors of 
COVID-19. The significant limitation of economic and social activities has led to unemployment, 
increased sedentary time, social isolation, and worsening of consequent increased incidence of 
mental health issues, all of which are well-recognized risk factors for CVD and associated with 
worsening CV outcomes. Moreover, it seems that patients with chronic CVD experienced 
worsening of health-related quality of life during the COVID-19 pandemic, despite stability of their 
CVD. (2) 
Thus, a dangerous link exists between CVD, depression and COVID-19, as these three conditions 
may co-exist and deleteriously affect each other, having a common, noteworthy risk factor, namely 
inflammation. Furthermore, gender has already been highlighted as a potential and relevant 
modifying factor both for CVD and depressive disorders (DD) as well as for COVID-19 short- and 
long-term outcomes. In particular, depression is still an under-recognized and under-treated risk 
factor for CVD, particularly in women, and COVID-19 pandemic is exacerbating gender-linked 
mental health challenges. (3, 4) 
Thus, the aim of this review is to provide a comprehensive analysis about the interplay between 
gender, depression, CVD and COVID-19, with a special focus on long COVID status.  
In this regard, we narratively reviewed the published literature (including searches in the 
MEDLINE [via PubMed] database) through March 2020. Articles were retrieved using keywords 
and medical subject heading terms related to COVID-19, SARS-CoV-2, depression, cardiovascular 
disease, and gender medicine.  
 




COVID-19 and depression in general population and in women  
Depression is a psychiatric condition characterized by alterations in regulators of mood, behavior 
and affection and represents one of the most common causes of disability in high-income countries, 
being associated with high societal and healthcare costs, both in terms of direct medical expenses 
and reduced work productivity associated with functional impairment.  
It is more prevalent in women than men, with a doubled worldwide chance of suffering from 
depression, especially during the mid-puberty and later life. About 20-25% of women go through 
depression during their life and depression symptoms have been considered a relevant emergent 
non-traditional risk factors for CVD in the female population. Moreover, patients with CVD suffer 
from depression more than the general population and people with depression are more prone to 
develop CVD, as they commonly adopt habits that overlap with CV risk factors. (4) 
A growing body of evidence is emerging about the effects of COVID-19 pandemic on mental health 
in the general population, resulting in identification of a number of clinical and demographical 
factors that predict the risk of depression. A meta-analysis of community-based studies about the 
prevalence of depression during COVID-19 pandemic, including a total of 12 studies, highlighted a 
pooled prevalence of depression of 25% (95% CI: 18%-33%), with significant heterogeneity 
between studies. (5)  Moreover, symptoms of depressive disorder increased considerably in the 
United States during April–June of 2020, compared with the same period in 2019. (6) 
Female gender firstly emerged as a significant risk for worsening health status and higher self-
reported depression symptoms, as women seem to have both a higher prevalence of risk factors 
known to intensify during a pandemic, including preexisting depressive and anxiety disorder, 
chronic environmental strain and domestic violence. Moreover, they experience pandemic-related 
stressors specific to reproductive functioning and stages, i.e. fertility issues, pregnancy, miscarriage, 
postpartum depression, intimate partner violence. (3) 
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A recent survey study by Perlis et al., including a total of 3904 individuals, investigated whether 
acute COVID-19 symptoms are associated with the probability of subsequent depressive symptoms. 
52.4% of patients met criteria for moderate or greater symptoms of major depression; at the 
regression analysis, these symptoms were more likely among younger individuals, men and among 
those with greater self-reported overall COVID-19 severity. (7) 
In particular, female gender, younger age, student and unemployment status, specific physical 
symptoms (i.e., myalgia, dizziness), and poor self-rated health status were firstly significantly 
associated with a greater psychological impact of the outbreak and higher levels of stress, anxiety, 
and depression. (8) Analogous data were described for the female health care workers. (9) 
Besides the short-term interaction between COVID-19 and depression, a considerable risk for 
psychiatric and neurological morbidity in the 6 months after COVID-19 infection exists, especially 
in patients who had severe COVID-19. (10, 11) 
Moreover, psychiatric morbidity at follow-up appears to be associated with persistent physical 
symptoms such as breathlessness and myalgia, the latter being associated with impaired quality of 
life, both in adults and young people. (12)  
Middle aged women, under the age of 50, seem to have a greater chance of suffering a variety of 
devastating ongoing symptoms, due to the presence of a persistent inflammatory burden, such as 
fatigue, breathlessness, muscle pain, anxiety, depression, and ―brain fog‖ after hospital treatment 
for COVID-19 (Table 1). (13) 
 
COVID-19, inflammation and cardiovascular disease in general population and in women  
Acute inflammation is a protective, time-limited, innate response that could be localized or 
systemic. When the threat that has triggered the inflammation has passed, the process resolves and 
the contraction of the immune response restores the initial homeostasis. An excessive acute 
response or the persistence of the systemic inflammation, and as a consequence of the immune 
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activation, is linked to several cardiovascular, neurodegenerative, and metabolic diseases, cancers, 
pathologies of the musculoskeletal system, and depression. (14) 
An overreaction of the innate response is one of the major drivers of the severe forms of COVID-19 
whose pathogenesis could be divided into three phases: (1) pulmonary, (2) inflammatory, and (3) 
prothrombotic. The pulmonary phase begins when the virus enters the respiratory system of the host 
and infects target cells. Binging and internalization of the infected target cells leads to a decrease in 
angiotensin-converting enzyme 2 (ACE2), and to a perturbation of the renin-angiotensin system 
(RAS), which damages the respiratory system. (15) In the inflammatory phase, the infection 
induces target and immune cells to produce a large amount of circulating proinflammatory 
cytokines and inflammatory markers—the so-called cytokine storm responsible for the acute lung 
injury in the severe forms of the disease. In the subsequent prothrombic phase, the systemic 
inflammatory response could trigger coagulopathy and multi-organ failure. (16) Hyperinflammation 
has been proposed as underlying mechanism predisposing patients with CVD for severe COVID-
19. (17) 
Thus, COVID-19 can induce profound alterations in the immune response that are influenced by the 
sex of the patients. First of all, in the general population, several sex differences exist in 
immunological parameters: males and females show differences in white cell count, neutrophil to 
lymphocyte ratio, and toll-like receptors, which are involved in the recognition of and response to 
microbial infections. (18) Moreover, males are overrepresented among patients with higher levels 
of pro-inflammatory markers, including C-reactive protein considered a marker of disease severity, 
associated with a subsequent higher risk of lung damage. (19) Compared to females, males with 
COVID-19 showed a higher plasmatic concentration of several proinflammatory cytokines and 
chemokines (IL-2, TNFα, IL-7, IL-18, CCL14, and CCL23). The fact that also anti-inflammatory 
cytokines such as IL-10 have been higher in males could be a mechanism to contain inflammation 
and tissue damages. (20) Furthermore, in males, higher expression of androgen could lead to 
enhanced expression of the transmembrane serine protease 2 (TMPRSS2), that is involved in the 
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process of priming of spike protein during SARS-COV2 infection, and this might be a potential 
reason for greater predisposition of males for COVID-19 infection. (21)  
These differences could influence the inflammation process, which resolves more rapidly in women 
than in men, probably due to the anti-inflammatory effects of estrogen. (22) It is not surprising, 
then, that sex differences influence not only the immune response to SARS-COV-2 but also the 
outcome of COVID-19, as well as drug absorption, metabolism and tolerance and, thus, COVID-19 
treatment efficacy. (21) Lastly, it seems that significant sex differences exist in long-term CV 
outcomes after COVID-19. (1, 23) Thus, the differences in the inflammatory burden between male 
and female population may explain the gender-related disparities both in COVID-19 clinical 
manifestations and in CV outcomes after COVID-19.  
The above-mentioned mechanisms may also be involved in the pathophysiology of long COVID, a 
condition wherein the affected individuals do not recover for several weeks or months following the 
onset of symptoms suggestive of COVID-19.  In general, women appear to be twice as likely to 
develop long COVID as men, but only until around age 60, when the risk level becomes similar. 
The cause for the symptoms of long COVID may be an extreme inflammatory response triggered 
by the virus, but also an autoimmune reaction ―unveiled‖ by the virus itself, possibly due to 
molecular mimicry with some components of our body. The autoimmune hypothesis could justify 
the higher incidence of this condition in women. (24) 
 
The potential relationship between COVID-19, depression and CVD  
What has happened in the last year as a result of the pandemic that has hit the whole world?  
An important increase in depression and stress was detected in different countries and affected all 
age groups, from children to the elderly. Although the methods adopted by countries to reduce the 
impact of the COVID-19 pandemic varied dramatically, the most common epidemiologic 
mitigation strategy throughout the world has been seen to impose quarantine and isolation at home. 
(25)  
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Although most publications explore the effects of COVID-19 on depression and stress in the 
general population or in population groups, little has been investigated on its effects on women. 
(26) Erving and coworkers examined whether stress exposures experienced within and across 
various life domains are predictors of depression among Afro–Caribbean women, a specific ethnic 
group within the black female population of the United States of America (USA). They specifically 
analyzed the relationship between 5 stress exposures and depression: major discrimination, 
everyday discrimination, past-month chronic stress, financial strain, and negative interactions with 
family. Of these five stress exposures, chronic stress and financial strain were associated with 
increased risk for depression. (27) During the pandemic, economic tension and chronic stress 
increased enormously, especially in the low-income segments of the population and in vulnerable 
individuals.  
Women have been strongly affected by quarantine for many reasons. The first reason is social; the 
woman has often primary roles as caregivers within families. The additional care burden associated 
with childcare and home education during blockages and caring for sick family members can lead 
to significant psychological distress leading to depression. Stay-at-home measures along with 
financial and security concerns can put a strain on families, which in some situations can lead to 
high stress levels in women. In addition, having less time for education, work, and career 
advancement, women can experience increased social inequality. Furthermore, in the case of 
women who live alone, isolation and the reduction of social relations together with the fear of the 
economic crisis favor the appearance of depression. (28)  
Several studies indicate that the COVID-19 pandemic has a disproportionately large economic 
effect on women because it affects the sectors in which they are most active. The manufacturing-
and-retail industry has experienced large fallbacks in export and sales because of lockdown and 
distancing measures. The World Trade Organization (WTO) reports that female employees make up 
80% of the workforce in manufacturing ready-made garments in Bangladesh, where industry orders 
fell by 81% in April 2020 alone. In addition, a greater proportion of women than men work in 
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tourism and business travel, which are severely disturbed by travel restrictions and will require a 
long recovery period. Furthermore, women are more frequently frontline health workers, thus 
potentially making them more susceptible to virus infection. (29) In this way, the pandemic has 
exacerbated financial entanglement, which represents a critical factor in intimate partner violence 
(IPV), along with social isolation and substance abuse (SU). IPV and SU share a multidirectional 
relationship that abruptly strengthened during COVID-19. Firstly, perpetrators of SU may enhance 
aggression and coercive behaviors and, thus, IPV; secondly, women who survive to IPV may 
themselves use substances to cope. Both SU and IPV significantly increased during COVID-19 
pandemic, with severe short and long-term mental health issues such as depression, a so-called 
―pandemic within a pandemic‖. (30)  
Wellbeing is a complex status that includes different features, such as health, emotions, 
relationships, and other quality-of-life dimensions. Stevenson and Wolfers observed a ‗paradox‘: 
despite improvement in their lives on many objective measures, women‘s happiness in the USA 
declined between 1972 and 2006. (31) There are several plausible explanations for this decline – for 
example, women may be held to higher expectations that are more difficult to meet. Stress and 
depression induced changes in lifestyle, promoting unhealthy diet, sedentary behavior and eat- 
drink for cope with stress. These changes in lifestyle seem to affect men and women in a different 
way. Women were more likely to develop food craving to cope with stress. Food craving is 
characterized by a high intake of fat- and sugar-rich foods leading to obesity. Obesity is a well-
known risk factor for COVID-19 and is associated with high levels of inflammation. (32)  
Several studies have suggested that a higher body mass index (BMI) or obesity are risk factors for 
complications arising from COVID-19 infection. (32) This may be due to several reasons: a higher 
prevalence of pulmonary problems in obese populations and a higher level of chronic inflammation 
and the adverse effect of obesity on diabetes. Again, a recent study showed that higher BMI was 
associated with a stronger risk of COVID-19 related mortality in women than in men. (33) Some 
evidence suggests that dietary patterns and individual nutrients can influence systemic markers of 
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immune functions. However, the complexity of the interaction (nutrition and immunology) 
necessitates further research. The Mediterranean diet is widely recognized to have anti-
inflammatory properties due to relatively high dietary intake of antioxidants and anti-inflammatory 
foods (vegetables, legumes, olive oil, whole grains, nuts, and monounsaturated fats). Moreover, 
several studies showed that adherence to a healthy dietary pattern, such as Mediterranean diet, is 
inversely associated with depression. (34)  
The association between diet and depression is independent from other confounding factors, such as 
body mass index, health behaviors, education and cultures. In turn, depression itself could affect 
eating habits leading to overeating and gain weight. Due to the restrictions imposed by the 
governments to stay at home, boredom and stress induced an increase in food consumption, which 
can lead to people inadvertently seeking comfort during times of stress.  During the COVID-19 
pandemic, a change in food choices has been reported suggesting a switch to unhealthy diet. An 
increase in the consumption of comfort food, such as chocolate, candies, chips and fast food take-
outs was reported in several countries. Moreover, due to change in social habits, the sales of coffee 
(15.2%), snacks and aperitifs have also increased. (35) On the other hand, the intake of fruits and 
vegetables was reduced.  
COVID-19 lockdown has further led to an increase in smoking due to time spent at home, mental 
distress and potential post-traumatic stress disorder (PTSD). It is well known that smoking habit in 
women leads to a significant early increase of CV risk and CVD. Cardio-metabolic health is strictly 
connected to sedentary behavior and physical activity. This has substantial immune and metabolic 
implications, especially in those at risk or with metabolic diseases including individuals with 
obesity and Type 2 diabetes. Furthermore, it is well known that women of all ages are less active 
than men.  
Although physical activity (PhA) plays a paramount role in reducing CVD-related incidents, recent 
data from clinical trials suggest that activity alone is not enough to reduce the risk of CVD in older 
adults. Both physical inactivity (PhI), defined as insufficient PhA level to meet present PhA 
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recommendations for age, and sedentary behavior (SedB), defined as any waking behavior 
characterized by an energy expenditure ≤1.5 metabolic equivalents (METs), while in a sitting, 
reclining or lying posture, have been recently identified as having negative impacts on health status 
in older adults. (36)  
A recent systematic review of 66 studies demonstrated that PhA significantly declined and SedB 
increased during the COVID-19 pandemic lockdown, regardless of the subpopulation or the 
methodology used. (37) Limited physical activity, increased sitting and screen time as a 
consequence of collective quarantine, may be associated with several metabolic effects that would 
increase the CV risk, especially in CVD patients, and the risk of severe COVID-19 outcomes as 
well. (38) It has also been established that many beneficial metabolic and CV adjustment in 
response to physical exercise can be lost in just two weeks of inactivity, impairing aerobic capacity, 
and/or increasing blood pressure. Again, physical inactivity and sedentary behavior are positively 
related to depression and reduction mental health. (39)  
COVID-19 related lockdowns have affected physical activity and sedentary behavior in both sex. 
However, during pandemic period, mental health was both a motivator and a barrier to PhA and 
women engaged in less PhA due to COVID-19 reported significantly lower mental health scores, 
lower social, emotional and psychological well being. (40) On the other hand, maintaining and 
enhancing physical activity participation showed to mitigate the mental health consequences of 
COVID-19. (41) Thus, given the several physical and mental benefits of increased PhA and 
decreased SedB, public health strategies should include the creation and implementation of 
interventions that promote safe PhA and reduce SedB (Table 2). Supervised long-term cardiac 
rehabilitation programs have been shown to be safe and effective during COVID-19 pandemic. (42)   
In summary, during COVID-19 and its aftermath it is imperative to consider the effects of the 
pandemic and social isolation on women‘s health, both in terms of CV and mental issues.  
Recent data showed that as the outbreak of COVID-19 has developed, referral rates to mental health 
and psychology services have significantly dropped, especially in female population, despite a 
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likely increase in psychological distress, IPV and SU. (43) Thus, healthcare providers‘ training must 
be enhanced to understand the additional burdens of depression and CVD and to increase help 
seeking in the context of COVID-19. A comprehensive action supporting physical activity and 
healthy diet is mandatory to encourage women to keep up an adequate lifestyle in order to manage 
both depression and CV risk factors.  
 
Conclusions 
The impact of depression on healthcare and social costs is crucial. The latter acts as a relevant 
modifiable CV risk factor and as one of the primary determinants of quality of life for cardiac 
patients. Moreover, depression has been identified as a significant short-term and long-term related 
complication of COVID-19 infection, with a remarkable impact on work productivity and 
disability. In particular, COVID-19 related depression might lead to a substantial increase in 
sedentary time, smoking habit and negative dietary behavior, which in turn are able to worsen CV 
outcomes.  
Furthermore, inflammation acts as the common pathophysiologic substrate both for COVID-19 and 
CV outcomes. Women seem to be less prone to COVID-19 infection and, thanks to the anti-
inflammatory effects of estrogens, experience a more rapid recovery from COVID-19. On the other 
hand, they undergo a disproportionately large economic and psychological effect during COVID-19 
pandemic, with an increased risk to develop mental health issues both on short and long term after 
COVID-19 infection, the latter being associated with a worsening of negative dietary and 
behavioral habits potentially related to CV risk. Moreover, middle-aged women appear to be twice 
as likely to develop long COVID as men, with a further negative effect both on mental disability 
and social and working concerns.  
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Thus, healthcare providers are strongly encouraged to inquire for depression among patients with 
ongoing or previous COVID-19 infection, and gender-specific issues must be taken into account to 
provide specific answers to male and female patients. In this view, specific protocols should be 
adopted in order to support and promote healthy lifestyle and adequate physical activity after 
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Table 1. Relevant clinical trials that explored the epidemiology of depression and mental health issues in COVID-19 and long COVID syndrome. 
References 
Total pts (n), 
% women (%) 
Population Aim Results 
Perlis R.et al 
(7) 
3904 (44.3%) 
US adult participants in 8 
waves of an internet-based 
nonprobability survey 
conducted by Qualtrics with 
multiple panels of 
respondents 
Association between acute 
COVID-19 symptoms and the 
probability of subsequent 
depressive symptoms. 
52.4% of participants met the criteria for symptoms of major 
depressive disorder. Presence of headache was associated with 
greater probability of moderate or greater depression symptoms 
(adjusted odds ratio [OR], 1.33; 95%CI, 1.10-1.62). Women were 
less likely to have symptoms than men (adjusted OR, 0.72; 95%CI, 
0.61-0.84). 




Retrospective cohort study 
from the TriNetX electronic 
health records network 
Incidence rates and relative 
risks of neurological and 
psychiatric diagnoses in patients 
in the 6 months following a 
COVID-19 diagnosis. 
The estimated incidence of a neurological or psychiatric diagnosis 
in the following 6 months was 33.62% (95% CI 33.17–34.07); the 
incidence of mood disorder was 13.66% (13.35-13.99%) in the 
whole population and increased in patients with hospitalization and 
with intensive therapy unit admission. 
Huang C.et al 
(11) 
1733 (48%) 
Patients with confirmed 
COVID-19 who had been 
discharged from Jin Yin-tan 
Hospital (Wuhan, China) 
between Jan 7, 2020, and 
May 29, 2020 
Describe the long-term health 
consequences of patients with 
COVID-19 who have been 
discharged from hospital and 
investigate the associated risk 
factors. 
Anxiety or depression was reported among 23% (367 of 1617) of 
patients. 
Naidu SB. et al 
(12) 
946 (39.8%) 
Adults discharged from 
hospital with a clinical 
diagnosis of COVID-19 
Evaluation of the mental health 
burden in adults discharged 
from hospital with COVID-19 
and exploration of the factors 
that contribute to this. 
13.8% of adults screened was positive for depression. Adults with 
positive PHQ-2 and TSQ were significantly more likely to 
experience persistent symptoms (PHQ2 80.0% vs. 41.8%, TSQ 
88.8% vs. 42.9%; both p<0.001) and they were also less likely to 
have returned to work (PHQ2 36.0% vs. 57.6%, p=0.004; TSQ 
37.5% vs. 56.5%, p=0.01). 
Torjesen I. (13) 1077 (36%) 
Adults discharged from 
hospital with a clinical 
diagnosis of COVID-19 
involving an assessment 
between two- and seven-
months later 
Impact of COVID-19 on health 
and employment, to identify 
factors associated with recovery 
and to describe recovery 
phenotypes. 
At follow-up only 29% felt fully recovered, 20% had a new 
disability, and 19% experienced a health- related change in 
occupation. Factors associated with failure to recover were female, 
middle- age, white ethnicity, two or more co-morbidities, and more 
severe acute illness. 
List of abbreviations: CVD, cardiovascular disease; Pts, patients; OR, odds ratio; AE, adverse events; DM, diabetes mellitus; PhA, physical activity; AMI, acute 
myocardial infarction; PHQ-9, Patient Health Questionnaire-9; CAG, coronary angiography; AF, atrial fibrillation; MSIMI, mental stress-induced myocardial. 
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Table 2. Practical suggestions for lifestyle and behavior activity in managing depression after pandemic COVID-19  
Contact friends and family 
Go outside, take short walk, and change your daily itinerary to avoid monotony 
Expose yourself to the sun 
Reduce sitting time (i.e., watching TV)  
Contact psychological support  












         
